Select Medical (SEM) Tops Q2 EPS by 1c; Authorizes $100M Buyback; Boosts FY11 EPS Outlook
Select Medical Holdings (NYSE: SEM) reported Q2 EPS of $0.20, $0.01 better than the analyst estimate of $0.19. Revenue for the quarter came in at $698.7 million versus the consensus estimate of $676.29 million.
Select Medical's board of directors has authorized a program to repurchase up to $100.0 million worth of shares of Select Medical's common stock.
Select Medical Holdings sees FY2011 EPS of $0.69-$0.74, versus prior guidance of $0.67-$0.72 and the consensus of $0.75. Select Medical Holdings sees FY2011 revenue of $2.65-$2.75 billion, versus the consensus of $2.72 billion.
Select Medical's board of directors has authorized a program to repurchase up to $100.0 million worth of shares of Select Medical's common stock.
Select Medical Holdings sees FY2011 EPS of $0.69-$0.74, versus prior guidance of $0.67-$0.72 and the consensus of $0.75. Select Medical Holdings sees FY2011 revenue of $2.65-$2.75 billion, versus the consensus of $2.72 billion.